Welcome to our dedicated page for Medical Prop SEC filings (Ticker: MPW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Medical Properties Trust Inc. filings document a self-advised REIT that owns and finances net-leased hospital real estate. Recent Form 8-K reports furnish operating and financial results, supplemental information, capital-allocation actions, Regulation FD communications, and other events, including the completed NYSE ticker change to MPT and the registration of common stock on the exchange.
Proxy materials describe board matters, executive compensation, equity awards and related shareholder voting disclosures. The filing record also covers the company's Maryland corporate status, common-stock capital structure, governance framework and formal exhibits used to report results and other material events for its healthcare real estate portfolio.
Medical Properties Trust (MPW) director Daniel Paul Sparks reported an equity award of 30,303 shares of common stock on January 8, 2026. The award was recorded at a price of $0 per share, indicating it is a stock-based compensation grant rather than an open‑market purchase.
After this grant, Sparks beneficially owns 150,546 shares of Medical Properties Trust common stock in direct form. According to the footnote, these shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, meaning the award will become fully vested over a three‑year period if service-based conditions are met.
Medical Properties Trust director Mozingo Caterina Ardon reported acquiring 30,303 shares of common stock on January 8, 2026 at a price of $0 per share, indicating a stock-based award rather than an open-market purchase. Following this transaction, she directly holds 110,468 shares of Medical Properties Trust common stock. According to the filing, these shares vest ratably at the beginning of each of the 12 calendar quarters starting on April 1, 2026, meaning the award is spread over three years of service.
Medical Properties Trust executive reports tax-related share withholding. SVP of Finance and Treasurer Charles R. Lambert had 2,836 shares of common stock withheld on January 9, 2026 at $5.04 per share in connection with the vesting of restricted stock, solely to cover tax obligations. According to the disclosure, this is not treated as a sale transaction. After this withholding, he beneficially owns 317,401 shares of Medical Properties Trust common stock directly.
Medical Properties Trust SVP of Operations Williams Rosa Handley reported an automatic share withholding tied to equity compensation. On January 9, 2026, 6,158 shares of common stock were withheld at $5.04 per share to cover tax obligations upon the vesting of restricted stock. The filing notes that this is not a sale transaction in the market. After this tax withholding event, Handley beneficially owned 389,024 shares of Medical Properties Trust common stock directly.
Medical Properties Trust Inc. senior vice president and senior advisor to the CEO, Larry H. Portal, reported an automatic share withholding tied to equity compensation. On January 9, 2026, 11,067 shares of common stock were withheld at $5.04 per share to cover tax obligations arising from the vesting of restricted stock. The filing states this withholding "does not constitute a sale transaction," meaning it was not an open-market sale. After this adjustment, Portal beneficially owned 470,624 shares of Medical Properties Trust common stock in direct ownership.
Medical Properties Trust insider reports tax withholding on vested stock. Senior VP, Controller & CAO James Kevin Hanna reported that on January 9, 2026, 9,274 shares of Medical Properties Trust common stock were withheld upon vesting of restricted stock to cover tax obligations at a reference price of $5.04 per share. The filing specifies this is not a sale transaction. After this withholding, Hanna directly holds 434,294 shares of the company’s common stock.
Medical Properties Trust executive Steven R. Hamner, Executive Vice President and CFO, reported equity award activity in the company’s common stock. On January 8, 2026, he was granted 509,124 shares tied to performance goals for debt reduction and cash revenue growth from January 1, 2026 through December 31, 2028, and 549,854 restricted shares that will vest in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. On January 9, 2026, 67,265 shares were withheld at $5.04 per share to satisfy tax obligations upon vesting of restricted stock, which is described as not constituting a sale. After these transactions, Hamner directly beneficially owned 3,889,568 shares of Medical Properties Trust common stock.
Medical Properties Trust Chairman, President & CEO Edward K. Aldag Jr. reported several stock-related transactions. On January 8, 2026, he was granted 1,018,247 shares of common stock that will be earned only if specific performance thresholds for reducing overall debt and growing cash revenue are met from January 1, 2026 through December 31, 2028, with a chance to earn up to one third based on 2026 results and further adjustment based on total shareholder return. The same day he also received 1,099,707 shares of common stock that vest in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. On January 9, 2026, 188,951 shares were withheld at $5.04 per share to cover tax obligations upon vesting of restricted stock, which is not treated as a sale. After these transactions, he directly beneficially owns 6,904,641 shares of common stock.
Medical Properties Trust Inc. received an updated large-shareholder disclosure from investor He Zhengxu on a Schedule 13G/A (Amendment No. 2). He reports beneficial ownership of 41,662,706 shares of the company’s common stock, representing 6.9% of the outstanding class as of the event date 12/31/2025. He, a United States citizen, has sole power to vote and dispose of all these shares, with no shared voting or dispositive power reported. The filing states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Medical Properties Trust.
Medical Properties Trust Inc. reported that its SVP of Operations sold 2,000 shares of common stock on 12/15/2025 at a price of $5 per share.
After this sale, the officer directly owned 395,182 shares of Medical Properties Trust common stock. No derivative securities transactions were reported in the derivative securities table.